IVERMECTIN SUBSTIPHARM Tablet Ref.[8797] Active ingredients: Ivermectin

Revision Year: 2018  Publisher: SUBSTIPHARM DEVELOPPEMENT, 24 rue Erlanger, 75016 Parijs, Frankrijk

Product name and form

IVERMECTIN SUBSTIPHARM 3 mg Tablets.

Pharmaceutical Form

Tablet.

The tablets are round, white or almost white, flat chamfered with a diameter of 5.5 mm and thickness of 2.1 mm.

Qualitative and quantitative composition

1 tablet contains 3 mg of ivermectin.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Ivermectin

Ivermectin is a member of the avermectin class and has high affinity with glutamate-gated chloride channels present in invertebrate nerve and muscle cells. Its binding to these channels promotes an increase in membrane permeability to chloride ions, leading to hyperpolarization of the neural or muscle cell. This results in neuromuscular paralysis and may lead to the death of certain parasites.

List of Excipients

Cellulose, microcrystalline (E460)
Pregelatinised maize starch
Butylhydroxyanisole (E320)
Magnesium stearate (E470b)

Pack sizes and marketing

4, 8, 10, 12, 16 or 20 tablets in aluminium/aluminium blisters.

Not all pack sizes may be marketed.

Marketing authorization holder

SUBSTIPHARM DEVELOPPEMENT, 24 rue Erlanger, 75016 Parijs, Frankrijk

Marketing authorization dates and numbers

RVG 120488

Date of first authorisation: 25 april 2018

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.